Research Article

Examining the Effector Mechanisms of the Feishu Acupoint (BL13) in the Treatment of Pneumonia Based on Systematic Acupuncture and Moxibustion Research

Table 4

Top 10 Reactome enrichment results for the Feishu point efficacy system.

Reactome IDReactome descriptionFDRMatched element

HSA-1280215Cytokine signaling in the immune system7.18E − 12ADAM17, CASP3, FASLG, FCER2, IFNGR1, IL12RB1, IL1B, IL2RB, IL4R, IL5RA, IL6R, MYD88, SQSTM1, STAT6, and TGFB1
HSA-449147Signaling by interleukins1.31E − 11CASP3, FASLG, FCER2, IL12RB1, IL1B, IL2RB, IL4R, IL5RA, IL6R, MYD88, SQSTM1, STAT6, and TGFB1
HSA-162582Signal transduction1.23E − 08ADAM17, BAD, BAX, CASP3, CCL1, CCR8, CDH1, CTNNBIP1, FAS, FASLG, FCER2, IL2RB, IL5RA, IL6R, MC2R, MYD88, SQSTM1, STAT6, TGFB1, and WNT3A
HSA-6785807Interleukin-4 and Interleukin-13 signaling3.34E − 08FASLG, FCER2, IL1B, IL4R, IL6R, STAT6, and TGFB1
HSA-73887Death receptor signaling1.62E − 07ADAM17, BAD, CASP3, FAS, FASLG, MYD88, and SQSTM1
HSA-168256Immune system4.40E − 07ADAM17, CASP3, CDH1, FASLG, FCER2, IFNGR1, IL12RB1, IL1B, IL2RB, IL4R, IL5RA, IL6R, MYD88, SQSTM1, STAT6, and TGFB1
HSA-109581Apoptosis9.96E − 06BAD, BAX, CASP3, CDH1, FAS, and FASLG
HSA-5357801Programmed cell death9.96E − 06BAD, BAX, CASP3, CDH1, FAS, and FASLG
HSA-193704p75 NTR receptor-mediated signaling1.68E − 05ADAM17, BAD, CASP3, MYD88, and SQSTM1
HSA-5357769Caspase activation via the extrinsic apoptotic signaling pathway0.00032CASP3, FAS, and FASLG